Potentiated by concurrent treatment with antithrombin III (human) in patients with hereditary antithrombin III deficiency; reduce heparin dose.

They exert their effect by binding to antithrombin, which inhibits both activated factor X and thrombin via a specific pentasaccharide sequence. This binding results in a conformational change in ...